Linking Genes to Diseases by Sifting Through Electronic Medical Records
By Carl Zimmer,
The New York Times
| 11. 28. 2013
The days of scrawled doctor’s notes are slowly coming to a close. In the United States, 93 percent of hospitals are now using at least some electronic medical records and 2.2 percent have given up paper records completely, according to the consulting firm
HIMSS Analytics.
The federal government has been pushing for electronic medical records for a decade,
arguing that they will improve health care and bring down costs. That is still a matter of debate. Critics
charge that the system is hobbled by poorly designed software and that some hospitals are using electronic medical records to
bill more for the same services.
But a new study suggests that electronic medical records may have another, entirely different use: as a Rosetta Stone for our DNA. Researchers are using them to trace links between genes and disease.
It has been
13 years since scientists first published the rough draft of the human genome and yet they are still just beginning to work out how our DNA influences our health. Most insights in recent years have come from so-called
genome-wide...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...